These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36185199)

  • 21. A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients.
    Liu L; Liang L; Mai G; Chen Y
    FASEB Bioadv; 2022 Sep; 4(9):585-601. PubMed ID: 36089979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy.
    Huang X; Sun Y; Song J; Huang Y; Shi H; Qian A; Cao Y; Zhou Y; Wang Q
    Front Immunol; 2023; 14():1301452. PubMed ID: 38045683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
    Liu X; Fang X; Lu L; Liu G
    Front Genet; 2022; 13():996625. PubMed ID: 36568396
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patients.
    Shen X; Zuo X; Liang L; Wang L; Luo B
    Front Immunol; 2023; 14():1162843. PubMed ID: 37207222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell Senescence-Related Genes as Biomarkers for Prognosis and Immunotherapeutic Response in Colon Cancer.
    Haibo Z; Tianyun L; Xiaoman C; Xiaoyan H
    Biochem Genet; 2024 Feb; ():. PubMed ID: 38411939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
    Gao H; Xing F
    BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes.
    Ren Y; He S; Feng S; Yang W
    Front Public Health; 2022; 10():916364. PubMed ID: 35712285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma.
    Wu D; Xiang L; Peng L; Gu H; Tang Y; Luo H; Liu H; Wang Y
    PLoS One; 2022; 17(10):e0276430. PubMed ID: 36264920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes.
    Huang X; Zhao C; Han Y; Li S
    Front Mol Biosci; 2023; 10():1143073. PubMed ID: 37363401
    [No Abstract]   [Full Text] [Related]  

  • 32. Glycosyltransferase-related long non-coding RNA signature predicts the prognosis of colon adenocarcinoma.
    Zhang J; Wu Y; Mu J; Xin D; Wang L; Fan Y; Zhang S; Xu Y
    Front Oncol; 2022; 12():954226. PubMed ID: 36203430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients.
    Zhang C; Zhao Z; Liu H; Yao S; Zhao D
    Front Genet; 2021; 12():657658. PubMed ID: 34322151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma.
    Zhou L; Zhang Y; Xu Y; Jiang T; Tang L
    Genes Genomics; 2023 Aug; 45(8):1047-1061. PubMed ID: 37318704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma.
    Li Y; Mo H; Wu S; Liu X; Tu K
    Front Cell Dev Biol; 2021; 9():801959. PubMed ID: 35047511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of prognostic models for colon adenocarcinoma based on combined immune-and metabolism-related genes.
    Jiang HZ; Yang B; Jiang YL; Liu X; Chen DL; Long FX; Yang Z; Tang DX
    Front Oncol; 2022; 12():1025397. PubMed ID: 36387195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid metabolism-related gene signature predicts prognosis and depicts tumor microenvironment immune landscape in gliomas.
    Li J; Zhang S; Chen S; Yuan Y; Zuo M; Li T; Wang Z; Liu Y
    Front Immunol; 2023; 14():1021678. PubMed ID: 36860853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
    Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
    Front Genet; 2022; 13():816173. PubMed ID: 35281843
    [No Abstract]   [Full Text] [Related]  

  • 40. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer.
    Yang X; Zhang C; Yan C; Ma L; Ma J; Meng X
    Aging (Albany NY); 2022 Nov; 14(22):9243-9263. PubMed ID: 36445321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.